Evidence map›Paper›PMID 24901871›Full record

ArticlePloS one2014

KIR2DS4 promotes HIV-1 pathogenesis: new evidence from analyses of immunogenetic data and natural killer cell function.

Aimee M Merino, Anne-Sophie Dugast, Craig M Wilson, Paul A Goepfert, Galit Alter, Richard A Kaslow, Jianming Tang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Association of KIR gene polymorphisms with COVID-19 disease.Clinical immunology (Orlando, Fla.) · 2022
    Article
  10. Review
  11. Genetic Variants inFrontiers in immunology · 2021
    Article
  12. Article
  13. A natural killer cell receptor takes sharp aim at the world of bacteria.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  14. Human NK cell receptor KIR2DS4 detects a conserved bacterial epitope presented by HLA-C.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Aimee M MerinoDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Anne-Sophie DugastRagon Institute of MGH, MIT, and Harvard, Boston, Massachusetts, United States of America.
Craig M WilsonDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Paul A GoepfertDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Galit AlterRagon Institute of MGH, MIT, and Harvard, Boston, Massachusetts, United States of America.
Richard A KaslowDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Jianming TangDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
University of Alabama at Birmingham · USRagon Institute of MGH, MIT and Harvard · US

Funding

CTL and HIV Polymorphisms in Heterosexual TransmissionR01AI064060 · NIAID · EMORY UNIVERSITY · PI GOEPFERT, PAUL A., HUNTER, ERIC · 2005 to 2019
$21.7M
Host Genetic Epidemiology in HIV-1-Discordant African Couples and Other CohortsR01AI071906 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI TANG, JIANMING · 2008 to 2012
$3.8M
ADOLESCENT MEDICINE HIV/AIDS RESEARCH NETWORKU01HD032830 · NICHD · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MOSCICKI, ANNA-BARBARA NONE · 1994 to 2001
$352k
NIAID NIH HHS AI071906NIAID NIH HHS R01 AI064060NIAID NIH HHS R01 AI071906NICHD NIH HHS U01-HD32830
6 · The paper itself

Abstract

backgroundKIR2DS4 gene variants encode full-length and truncated protein products, with only the former serving as membrane-bound receptors to activate natural killer (NK) cells. We have previously shown that full-length KIR2DS4 was associated with relatively high viral load and accelerated heterosexual HIV-1 transmission. Our objective here was to provide confirmatory data and to offer new insights about the potential mechanisms. METHODOLOGY/PRINCIPAL

findingsMixed models for repeated (longitudinal) outcome measurements on 207 HIV-1 seropositive American youth revealed an association of full-length KIR2DS4 with relatively high viral load and low CD4+ T-cell count (p<0.01 for both). Depending on KIR2DS4 expression (presence or absence) on cell surface, NK cells from 43 individuals with untreated, chronic HIV-1 infection often differed in functional properties, including degranulation and secretion of IFN-γ and MIP-1β. In particular, polyfunctional NK cells were enriched in the KIR2DS4-positive subset. CONCLUSIONS/SIGNIFICANCE: Full-length KIR2DS4 promotes HIV-1 pathogenesis during chronic infection, probably through the maintenance of an excessively pro-inflammatory state.

Indexed as

AdolescentCD4-Positive T-LymphocytesCell LineChronic DiseaseCross-Sectional StudiesFemaleGenotypeHIV-1HIV InfectionsHLA AntigensHumansKiller Cells, NaturalLinear ModelsLongitudinal StudiesMaleReceptors, KIRHLA AntigensKIR2DS4 protein, humanReceptors, KIR

Identifiers

PMID24901871
PMCPMC4047121
OpenAlexW2114459438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.